KYMR
Kymera Therapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Kymera Therapeutics (KYMR) Stock: Buy, Sell, or Hold?
$134.84
-1.80 (-1.32%)
▼
5d:
-1.03%
30d:
+26.4%
90d:
+17.85%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Oct 29, 2026
0d
Protect KYMR Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (17%)
Quality Score
31/100
Position
EXTENDED
30-Day Fair Range
$107.34 – $128.76
Position: EXTENDED
Forward P/E & Valuation
-26.4x
Next 12M consensus est.
Wall Street Target
$145.22
+7.7% upside
Options IV & Volume
87th pct IV
HIGH volume confirmation
Support / Resistance
$117.31 / $142.92
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: KYMR shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When KYMR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: KYMR is currently trading at $134.84, which is considered extended relative to its 30-day fair value range of $107.34 to $128.76.
Technical Outlook: Technically, KYMR is in a uptrend. Immediate support is located at $117.31, while resistance sits at $142.92.
Market Sentiment: KYMR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Implied Volatility is high (87th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KYMR is in a uptrend. Immediate support is located at $117.31, while resistance sits at $142.92.
Market Sentiment: KYMR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Implied Volatility is high (87th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$107.34 -
$128.76
Company Quality Score
31/100
(SELL)
Options IV Signal
87th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
16.7%
Trading Range & Key Levels
30-Day Trading Range
$107.34 -
$128.76
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$30.07
(22.3%)
Support Level
$117.31
Resistance Level
$142.92
Current Trend
Uptrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding KYMR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Options expensive (IV 87th percentile)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($145.22)
- WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-26.35
Wall Street Target
$145.22
(+7.7%)
Revenue Growth (YoY)
466.4%
Share KYMR Analysis
Share this live KYMR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (KYMR)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 28, 2026
Daily AI digest
AI Retail Discussion Summary:
Investors are bullish on $KYMR ahead of earnings, with focus on the potential of lead immunology candidate KT-621. Kymera Therapeutics is priced below analyst target and trades on a significant cash runway, implying potential for long-term earnings growth.
Key Retail Themes:
Upcoming earnings report
Potential of KT-621
Valuation and fair value estimates
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:51 AM ET
Data refreshes hourly during market hours. Next update: 2:51 AM
Data refreshes hourly during market hours. Next update: 2:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KYMR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 49 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 34 SELL |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 32 SELL |
|
PALI
Palisade Bio Inc |
STRONG BUY
10 analysts |
$10 | 62 BUY |
|
ZYME
Zymeworks Inc. Common St… |
STRONG BUY
14 analysts |
$42 | 42 HOLD |
Advanced KYMR Option Strategies
Professional options setups generated by AI based on today's KYMR price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive KYMR Research Pages
